Mr. Iram Ron joined Pre-Clinical Group and Vetgenerics Research G. Ziv Ltd. as Managing Director in1998. Together with Dr. Shem-tov he established Vetgenerics as a leading CRO in the area of international veterinary clinical studies for pharmaceuticals and feed additives. In 2004 Iram Ron expanded Vetgenerics Research activities and founded Pre-Clinical Group. Mr. Iram Ron manages the marketing and business operations at Pre-Clinical Group and Vetgenerics
Scientific Director Motti Shem-Tov, PhD
Dr.Motti Shem-Tov, is one of the founders of Pre Clinical Group. Dr. Shem-Tov also founded the sister company Vetgenerics Research with the late Prof. G. Ziv in the year 1996. Dr. Shem-Tov received his MSc and PhD from the Hebrew University of Jerusalem, writing his thesis in Pharmacokinetic/pharmacodynamic relationships of antibiotics. His research interests are mainly focused in ADME research in laboratory and farm animals. Before founding Vetgenerics Research he was a researcher in the Kimron veterinary Institute, Study Director in the Israeli Biological Research Institute. Dr. Shem0Tov ia a pre-clinical expert and advises international and local biotechnological and pharmaceutical companies in relevant aspects of drug development.
Dr. Shem-Tov has considerable experience and expertise in experimental in vivo models for drug development, bioanalytical chemistry, experimental models for feasibility and for efficacy studies in wide range of developments such as cancer, wound healing, cardiovascular, CNS, pharmacologly/toxicology risk assessment and development.
Dr. Shem-Tov has published more than 15 original peer-reviewed articles. He has actively participated to over 30 international scientific congresses. Dr. Shem-Tov lectures in pharmacology and toxicology with Prof. Stefan Soback in the Hebrew University Faculty of agriculture animal science and veterinary.
Regulatory Affairs &Compliance Guy Wagner M. Pharm.
Mr. Guy Wagner Earned a Pharmacy degree and a Masters degree from the Hebrew University of Jerusalem (specializing in Pharmaceutical Chemistry).
Mr. Wagner was employed in various managerial positions in the Biotechnical Pharmaceutical Industry, specializing in sterile manufacturing and later on managing in QA and validation projects. Mr. Wagner has been involved in regulatory affairs for the past ten years, providing a wide scope of expertise in GLP/GMP/GCP support, Documentation practices, regulatory development plans, submission of regulatory dossiers and interaction with authorities and advanced training.
